CBRE vs NDRA · P/E 43, rev $35.77B vs P/E 0.0, $2.6M cap
CBRE Group Inc Class A (CBRE) versus ENDRA Life Sciences Inc (NDRA) — a side-by-side from cached financials, not a winner call.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Latest reported CBRE revenue for 2024-12-31 was $35.77B. Net income was $1.04B. Revenue was up 12.0% from 2023-12-31 to 2024-12-31. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
NDRA does not have a complete income-statement cache yet.
CBRE currently screens at market cap $41.66B and trailing P/E 42.7. NDRA currently screens at market cap $2.6M and trailing P/E 0.0.
Not investment advice. Open the CBRE and NDRA stock pages for the full models.
Not investment advice.